Mayo Clinic's approach

A team of doctors and staff in a discussion. Mayo Clinic heart transplant team

A team of doctors and other staff work together and discuss care for people who may need a heart transplant.

Multidisciplinary team approach

At Mayo Clinic, doctors trained in heart disease (cardiologists), heart and lung surgery (cardiac and thoracic surgeons), infectious disease management, mental health conditions (psychiatrists), and other specialties collaborate as a multidisciplinary team to provide you with coordinated, comprehensive care. Doctors work together with health care professionals in many areas to evaluate you, perform your heart transplant and coordinate follow-up care.

Image of health care professionals in many medical specialties. Care team roles

Health care professionals trained in many medical specialties work together as a team to ensure favorable outcomes from your heart transplant.

Pediatric cardiologists, pediatric heart surgeons and other specialists work together to evaluate and treat children who may need heart transplants at Mayo Clinic's campus in Minnesota. At Mayo Clinic's campus in Arizona, cardiologists partner with Phoenix Children's Hospital to treat teenagers and young adults with congenital heart disease.

Multiorgan transplant experience

Mayo Clinic doctors and surgeons have experience evaluating and treating people with complex conditions who may need multiorgan transplants. Surgeons have experience performing multiorgan transplant procedures, such as heart-kidney, heart-liver and heart-lung transplants. A team of doctors trained in a wide array of specialties works together in Mayo Clinic's Transplant Center to treat people who may need multiorgan transplants.

Amyloidosis expertise

Mayo doctors have extensive experience and expertise evaluating and treating people with amyloidosis.

Amyloidosis is a rare disease that occurs when a substance called amyloid builds up in organs in your body. Amyloidosis can affect the function of many organs in your body.

If amyloidosis has seriously affected your heart, you may be eligible for a heart transplant or a heart-liver transplant. Your Mayo doctors and treatment team will evaluate your condition and determine if a heart transplant or other treatment may be most appropriate for your condition. Doctors at Mayo Clinic have experience treating amyloidosis with many treatments, including heart transplant for people who are eligible.

Individualized approach

Mayo Clinic doctors take the time to get to know you and work with you to provide exactly the care you need. Your doctors and transplant team will work with you and discuss your individual needs, desires and lifestyle to determine the most appropriate treatment for you.

Depending on your individual condition and needs, your doctors and transplant team may recommend a heart transplant or other therapies, such as a ventricular assist device.

Two doctors having a discussion. Mayo Clinic doctors collaborate to provide care

Mayo doctors collaborate as a team to care for people who may need a heart transplant.

Common recommendations and treatment at all Mayo Clinic locations

Mayo Clinic's Transplant Center staff at Mayo Clinic's campuses in Arizona, Florida and Minnesota works together to evaluate and treat people who may need a heart transplant. Mayo Clinic offers common recommendations, evaluation processes, treatment, post-surgical care and follow-up care for heart transplant candidates at Mayo Clinic's campuses in Arizona, Florida and Minnesota. Mayo Clinic uses technology to help make patient information available as needed at all three locations.

Mayo Clinic staff coordinates care as needed between the three sites. You may be evaluated for a heart transplant at one Mayo Clinic location, but you may have a heart transplant at another location if it's in your best interest. If you have your evaluation and transplant surgery at different locations, Mayo staff from both locations collaborates as a team to provide you with comprehensive care through the transplant process.

Research and innovation

Mayo Clinic researchers in the Transplant Center conduct ongoing studies and clinical trials in improving surgical procedures, improving outcomes and caring for people who need transplants. Research also studies alternative therapies for people who may not need a transplant.

Mayo researchers also study medications and treatments for people who have had heart transplants, including new medications (immunosuppressant medications) to keep your body from rejecting your heart transplant.

For example, Mayo doctors have studied using sirolimus (Rapamune) as an immunosuppressant for people who have had heart transplants. Mayo Clinic doctors may recommend that some people use sirolimus instead of calcineurin inhibitors. Some people may need to continue using calcineurin inhibitors with sirolimus, but the dose of the calcineurin inhibitors may be lowered.

Sirolimus may help slow the progress of kidney problems or improve kidney function. It may also prevent or slow the progress of a disease that can occur after a heart transplant called cardiac allograft vasculopathy. In this disease, the walls of the arteries in your heart (coronary arteries) thicken and harden, which can cause limited blood flow through your heart.

Mayo Clinic doctors also use innovative imaging tests to detect signs of complications in your coronary arteries, such as cardiac allograft vasculopathy, after your heart transplant.

For example, Mayo doctors may use optical coherence tomography (OCT) — an imaging test that uses light waves to provide cross-sectional images of the arteries — to monitor for signs of narrowing and blockages in the coronary arteries. At Mayo Clinic, OCT may sometimes be used in combination with coronary angiography to detect coronary artery disease.

A doctor stands by a person and conducts an imaging test Using imaging tests to detect coronary artery disease

Mayo doctors may use imaging tests, such as optical coherence tomography (OCT), to monitor for signs of narrowing and blockages in the coronary arteries.

Aug. 18, 2016
References
  1. What is a heart transplant? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/ht. Accessed April 8, 2016.
  2. Mancini D. Indications and contraindications for cardiac transplantation. http://www.uptodate.com/home. Accessed April 8, 2016.
  3. Colvin M, et al. OPTN/SRTR annual data report 2014: Heart. American Journal of Transplantation. 2016;16:115.
  4. What is a ventricular assist device? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/vad. Accessed April 7, 2016.
  5. What is a total artificial heart? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/tah. Accessed April 12, 2016.
  6. Flynn B, et al. Heart and lung transplantation. Current Opinion in Anaesthesiology. 2014;27:153.
  7. Goldman L, et al., eds. Cardiac transplantation. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed April 7, 2016.
  8. Pham MX. Prognosis after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
  9. Pham MX. Induction and maintenance of immunosuppressive therapy in cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
  10. Pina IL. Rehabilitation after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
  11. McKenna WJ. Treatment of amyloid cardiomyopathy. http://www.uptodate.com/home. Accessed April 1, 2016.
  12. What are the risks of heart surgery? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hs/risks. Accessed April 12, 2016.
  13. Barbara Woodward Lips Patient Education Center. Heart transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  14. Partnering with your transplant team: The patient's guide to transplantation. U.S. Department of Health and Human Services. https://optn.transplant.hrsa.gov/learn/patient-education/. Accessed April 12, 2016.
  15. What every patient needs to know. United Network for Organ Sharing. http://www.transplantliving.org/community/patient-resources/publications/. Accessed April 13, 2016.
  16. Diet and exercise. United Network for Organ Sharing: Transplant living. http://www.transplantliving.org/after-the-transplant/staying-healthy/diet-and-exercise/. Accessed April 13, 2016.
  17. Eisen HJ. Prevention and treatment of cardiac allograft vasculopathy. http://www.uptodate.com/home. Accessed April 13, 2016.
  18. Topilsky Y, et al. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012;125:708.
  19. Transplant gives recipient chance to re-establish priorities. Mayovox. August 1988;39:1.
  20. Heart transplant program to resume in fall of 1986. Mayovox. January 1986;37:1.
  21. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 8, 2016.
  22. Matsuo Y, et al. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. The Journal of Heart and Lung Transplantation. 2013;32:784.
  23. Gertz MA, et al. Pathophysiology and treatment of cardiac amyloidosis. Nature Reviews Cardiology. 2015;12:91.
  24. Williams BA, et al. Heart failure and heart rhythm disorders. In: Current Diagnosis & Treatment: Geriatrics. 2nd ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://www.accessmedicine.com. Accessed April 21, 2016.
  25. Guddetti RR, et al. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy. Circulation: Cardiovascular Imaging. 2015;8:e002636.
  26. Yancy CW, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62: e147.
  27. Yip DS (expert opinion). Mayo Clinic, Jacksonville, Fla. May 24, 2016.
  28. Medical practice report: Heart transplant. Press Ganey. http://www.pressganey.com/. Accessed May 24, 2016.
  29. Lund LH, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report — 2015; focus theme: Early graft failure. The Journal of Heart and Lung Transplantation. 2015;34:1244.

Connect with others

News, connections and conversations for your health

Recent posts